Rutabaga Capital Management Upped Orchids Paper Products Company (TIS) Position; Shorts at Abbvie (ABBV) Lowered By 11.06%

December 6, 2017 - By Jan Rainey

Rutabaga Capital Management Llc increased Orchids Paper Products Company (TIS) stake by 46.22% reported in 2017Q2 SEC filing. Rutabaga Capital Management Llc acquired 95,026 shares as Orchids Paper Products Company (TIS)’s stock declined 54.86%. The Rutabaga Capital Management Llc holds 300,636 shares with $3.89M value, up from 205,610 last quarter. Orchids Paper Products Company now has $139.49 million valuation. The stock decreased 3.22% or $0.44 during the last trading session, reaching $13.38. About 27,191 shares traded. Orchids Paper Products Company (NYSEMKT:TIS) has declined 56.11% since December 6, 2016 and is downtrending. It has underperformed by 72.81% the S&P500.

Abbvie Incorporated (NYSE:ABBV) had a decrease of 11.06% in short interest. ABBV’s SI was 12.64 million shares in December as released by FINRA. Its down 11.06% from 14.21 million shares previously. With 7.65 million avg volume, 2 days are for Abbvie Incorporated (NYSE:ABBV)’s short sellers to cover ABBV’s short positions. The stock decreased 1.26% or $1.2 during the last trading session, reaching $94.21. About 1.37M shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since December 6, 2016 and is uptrending. It has underperformed by 6.07% the S&P500.

Among 2 analysts covering Orchids Paper Products Co (NYSEMKT:TIS), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Orchids Paper Products Co had 4 analyst reports since October 15, 2015 according to SRatingsIntel. Oppenheimer maintained Orchids Paper Products Company (NYSEAMERICAN:TIS) rating on Tuesday, October 27. Oppenheimer has “Outperform” rating and $33.0 target.

Rutabaga Capital Management Llc decreased Dmc Global Inc stake by 77,277 shares to 548,473 valued at $7.19M in 2017Q2. It also reduced Libbey Inc (NYSEMKT:LBY) stake by 74,184 shares and now owns 694,680 shares. Tivity Health Inc was reduced too.

Since June 14, 2017, it had 0 insider purchases, and 2 selling transactions for $8.79 million activity. $3.21 million worth of AbbVie Inc. (NYSE:ABBV) was sold by ALBAN CARLOS on Wednesday, June 14. Schumacher Laura J sold $5.59 million worth of stock or 79,800 shares.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company has market cap of $150.40 billion. The firm offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA, an oral therapy for the treatment of patients with chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, for the treatment of adults with genotype 1 chronic hepatitis C. It has a 22.88 P/E ratio. It also provides Kaletra, an anti- human immunodeficiency virus-1 medicine used with other anti-HIV-1 medications as a treatment that maintains viral suppression in HIV-1 patients; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and Synagis to prevent RSV infection at-risk infants.

Investors sentiment increased to 1 in Q2 2017. Its up 0.01, from 0.99 in 2017Q1. It is positive, as 55 investors sold AbbVie Inc. shares while 581 reduced holdings. 138 funds opened positions while 500 raised stakes. 1.04 billion shares or 0.53% more from 1.04 billion shares in 2017Q1 were reported. Seabridge Inv stated it has 2,600 shares. Cordasco Networks reported 0.16% stake. Barr E S And invested 0.05% in AbbVie Inc. (NYSE:ABBV). Torray Limited Liability holds 13,645 shares. Stevens First Principles Inv Advisors has 95 shares for 0% of their portfolio. Middleton And Ma has invested 2.17% in AbbVie Inc. (NYSE:ABBV). Busey Trust has invested 0.28% of its portfolio in AbbVie Inc. (NYSE:ABBV). Shelton Mngmt invested 0.41% in AbbVie Inc. (NYSE:ABBV). Clinton Group owns 0.41% invested in AbbVie Inc. (NYSE:ABBV) for 55,912 shares. Jpmorgan Chase Com reported 0.06% of its portfolio in AbbVie Inc. (NYSE:ABBV). Kidder Stephen W, Massachusetts-based fund reported 36,805 shares. Northeast Financial Consultants Inc invested in 2,920 shares. Brandywine Tru Company reported 161,371 shares or 12.3% of all its holdings. Cognios Cap Ltd Llc has invested 0.09% in AbbVie Inc. (NYSE:ABBV). Wms Prtnrs Lc owns 9,669 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.